This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bostongene Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Siune Ambarian: Innovator in Cancer Research
Introduction
Siune Ambarian is a prominent inventor based in Yerevan, Armenia. He has made significant contributions to the field of cancer research, particularly in understanding tumor microenvironments. His innovative work focuses on the mechanisms of immune escape and immune infiltration in various cancers.
Latest Patents
Siune Ambarian holds a patent for a groundbreaking invention titled "Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration." This patent encompasses methods, systems, and computer-readable storage media that are instrumental in characterizing subjects with specific cancers, especially those characterized by solid tumors. The invention is pivotal in determining the tumor microenvironment (TME) type of a cancer subject, which aids in assessing the subject's prognosis and the likelihood of responding to various therapies based on the TME type determination. He has 1 patent to his name.
Career Highlights
Siune Ambarian is currently associated with Bostongene Corporation, where he continues to advance his research in cancer diagnostics and treatment. His work is vital in the ongoing efforts to improve cancer care and patient outcomes.
Collaborations
Siune collaborates with talented individuals in his field, including Sofya Kust and Anastasia Zotova. Their combined expertise contributes to the innovative projects at Bostongene Corporation.
Conclusion
Siune Ambarian's contributions to cancer research through his patent and work at Bostongene Corporation highlight his commitment to improving cancer diagnostics and treatment. His innovative approaches are paving the way for advancements in understanding and treating cancer effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
